Article
Zebrafish screen identifies novel compound with selective toxicity against leukemia
9 Apr 2012
Abstract excerpt
To detect targeted antileukemia agents we have designed a novel, high-content in vivo screen using genetically engineered, T-cell reporting zebrafish. We exploited the developmental similarities between normal and malignant T lymphoblasts to screen a small molecule library for activity against immature T cells with a simple visual readout in zebrafish larvae. After screening 26 400 molecules, we identified...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
